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polyBall: A new adsorbent for the 
efficient removal of endotoxin from 
biopharmaceuticals
Sidharth Razdan, Jee-Ching Wang & Sutapa Barua  
The presence of endotoxin, also known as lipopolysaccharides (LPS), as a side product appears 
to be a major drawback for the production of certain biomolecules that are essential for research, 
pharmaceutical, and industrial applications. In the biotechnology industry, gram-negative bacteria 
(e.g., Escherichia coli) are widely used to produce recombinant products such as proteins, plasmid 
DNAs and vaccines. These products are contaminated with LPS, which may cause side effects when 
administered to animals or humans. Purification of LPS often suffers from product loss. For this reason, 
special attention must be paid when purifying proteins aiming a product as free as possible of LPS 
with high product recovery. Although there are a number of methods for removing LPS, the question 
about how LPS removal can be carried out in an efficient and economical way is still one of the most 
intriguing issues and has no satisfactory solution yet. In this work, polymeric poly-ε-caprolactone (PCL) 
nanoparticles (NPs) (dP = 780 ± 285 nm) were synthesized at a relatively low cost and demonstrated 
to possess sufficient binding sites for LPS adsorption and removal with ~100% protein recovery. The 
PCL NPs removed greater than 90% LPS from protein solutions suspended in water using only one 
milligram (mg) of NPs, which was equivalent to ~1.5 × 106 endotoxin units (EU) per mg of particle. 
The LPS removal efficacy increased to a higher level (~100%) when phosphate buffered saline (PBS 
containing 137 mM NaCl) was used as a protein suspending medium in place of water, reflecting positive 
effects of increasing ionic strength on LPS binding interactions and adsorption. The results further 
showed that the PCL NPs not only achieved 100% LPS removal but also ~100% protein recovery for a 
wide concentration range from 20–1000 μg/ml of protein solutions. The NPs were highly effective in 
different buffers and pHs. To scale up the process further, PCL NPs were incorporated into a supporting 
cellulose membrane which promoted LPS adsorption further up to ~100% just by running the LPS-
containing water through the membrane under gravity. Its adsorption capacity was 2.8 × 106 mg of PCL 
NPs, approximately 2 -fold higher than that of NPs alone. This is the first demonstration of endotoxin 
separation with high protein recovery using polymer NPs and the NP-based portable filters, which 
provide strong adsorptive interactions for LPS removal from protein solutions. Additional features of 
these NPs and membranes are biocompatible (environment friendly) recyclable after repeated elution 
and adsorption with no significant changes in LPS removal efficiencies. The results indicate that PCL 
NPs are an effective LPS adsorbent in powder and membrane forms, which have great potential to be 
employed in large-scale applications.
In biotechnology industries, gram-negative bacteria are widely used for the production of therapeutic biomole-
cules including proteins, peptides, and nucleic acids1–6. These biomolecules are recovered by cellular rupturing 
that leads to the release of a large number of bacterial cell-wall components containing endotoxins, also known as 
lipopolysaccharides (LPS)7–9. When the LPS contaminated products are administered to animals or humans even 
in small quantities (0.05–0.1 ng/ml), a systemic inflammatory reaction can occur, leading to multiple pathophys-
iological effects, such as septic shock, tissue injury, and lethality10,11. Removing undesirable LPS from solutions 
is thus an important aim in the pharmaceutical industry and in clinical practice. Conventional treatments such 
as coagulation and membrane filtration are adequate for removing bacteria cells and debris but not effective for 
removing dissolved endotoxins to a significant extent. Therefore, it is highly desirable and also the focus of this 
project to develop a biodegradable and inexpensive means that can tackle both aspects of LPS removal.
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A number of approaches have been developed and typically utilized to reduce LPS concentration in phar-
maceutical solutions and therapeutic products or in purified water8,12–33. These approaches employ activated 
carbon34,35, gel filtration chromatography12–15, ion exchange or size exclusion chromatography16–20, sucrose gra-
dient centrifugation36–38, Triton X-114 phase separation39–41, ultrafiltration21,22, microfiltration21,22 and affinity 
adsorbents23–28, functionalized with L-histidine42, poly(ethylene imine) (pEI)23, poly-ε-lysine, poly(γ-methyl 
L-glutamate), or polymyxin B8,29–33. and chemical means such as ozonation and chlorination35,43. More recently, 
nanoparticle (NP)-based methods have also been attempted and shown great promise44–46. Polymyxin B capped 
silver (Ag) NPs have been used to remove LPS from aqueous solutions, up to 97% efficiency, based on the ionic 
interaction between the cationic peptide on Polymyxin B and the anionic phosphate on Lipid A of LPS44. Surface 
modified iron oxide (Fe3O4) gold (Au) core-shell nanoflowers (NFs) have been explored for simultaneous reduc-
tion and detection of LPS as alternatives to classical methods of endotoxin sensing47. Also, NPs with a polysty-
rene core and a polyglycidyl methacrylate shell have been synthesized and further modified with amine-based, 
amino acid based, pEI, tetracaine, or Polymyxin B ligands for LPS removal from water and salt solution46. The 
parent particles modified with amine-based (ethylene diamine, hexamethylene amine, and dodecyl diamine) and 
pEI ligands showed significant LPS removal efficiency around 90% from both water and salt solution, whereas 
those modified with tetracaine, amino acid lysine, and amines (histamine and tryptamine) showed a higher LPS 
removal efficiency from water, also around 90%, than from salt solution46. While showing great promise, these 
approaches at present still have their shares of limitations and disadvantages in terms of cost, efficiency, degra-
dability, side effects, and/or accompanying toxicity brought by the reagents. For examples, the methods utilizing 
porous functionalized NPs are reasonably effective in reducing the LPS concentration; however, their operations 
are relatively expensive due to the use of high-pressure equipment that adds significant cost to downstream puri-
fication and are contingent on the slow processes of intraparticle diffusion and solute retention on the binding 
sites48–50. Polymyxin B, a polypeptide antibiotic, can also cause neurotoxicity and nephrotoxicity.
A key step forward with the NP-based approach is to establish a high throughput, low-cost method that 
is not subject to high pressure-drop limitation, slow solute transport, or accompanying toxicity. To this end, 
poly-ε-caprolactone (PCL) NPs without any modification have been manufactured in the PI’s laboratory, which 
are non-porous solid adsorbent nanoparticles with solute binding sites situated on the particle surface. The NPs 
were found to be capable of adsorbing and removing LPS from protein solutions at efficiency up to 100%. Their 
prospects for technological application were further substantiated by the processing feasibility of incorporating 
PCL NPs into membrane filters and high LPS reduction and removal from biological solutions using cellulose 
membranes embedded with PCL NPs. In either powder form or in a spread bed of a flat sheet membrane, PCL 
NPs offer high adsorption capacity per unit mass of the adsorbents. Since PCL and cellulose are both low-cost 
biocompatible polymers51–53, the use of such PCL NP-embedded membranes represents a novel LPS separation 
system that requires low capital costs but provides desirable ease of manufacturing, excellent performance, dis-
posability, and biodegradability.
Materials and Methods
Synthesis of PCL nanoparticles. PCL NPs were synthesized by the solvent evaporation method which 
utilized high–speed homogenization and sonication, followed by solvent evaporation, centrifugation to remove 
surfactants, and then lyophilization54–58. A PCL solution at a concentration of 10 mg/ml in ethyl acetate was 
injected using a syringe pump to a 1% w/v polyvinyl alcohol (PVA) solution prepared with reverse osmosis (RO) 
water. The mixture was homogenized by using a homogenizer rotating at 3000 rpm while being placed in a son-
ication bath. Ethyl acetate was removed by stirring the mixture at 300 rpm for two days. The obtained particles 
were washed five times using RO water and centrifuged for 30 minutes at 10,000 rcf. The resulting products were 
freeze-dried, weighed, and stored at 4 °C until further use. To test the effects of cationic charges on bare PCL NP, 
10 mg of freeze-dried PCL NPs were coated with cationic PLL solution by incubating with 1 ml of 0.1% (w/v) PLL 
(Sigma) for 1 h. Post incubation the particle suspension was centrifuged for 30 min at 16,000 rcf and the superna-
tant was separated to obtain positively charged PLL coated PCL NPs.
Characterization of PCL nanoparticles. The morphology of PCL NPs was observed using Hitachi S-4700 
scanning electron microscope (SEM) at an accelerating voltage of 15 kV. Samples were sputter coated with Denton 
Au/Pd coater before inserting it into the microscope. The average PCL particle size was measured by analyzing the 
SEM images using the ImageJ software (version 1.51w). The average particle size was reported as mean ± standard 
deviation (SD) based on the diameters of 200 randomly selected particles. The hydrodynamic size and surface 
charge of NPs were characterized by dynamic light scattering (DLS) and zeta ζ( ) potential measurements, respec-
tively using Malvern NanoZS90 Zetasizer. The hydrodynamic diameter of PCL NPs was measured at 25 °C using 
He-Ne Lasers at 90° scattering angle. The size distribution was obtained based on three independent experiments 
utilizing 100 successive runs. Zeta potential values were reported based on three independent experiments with 
each experiment utilizing 15 successive runs and the results were reported as millivolts (mV) ± SD.
Adsorption studies. Escherichia coli O111: B4 LPS (Sigma Aldrich) was used to study the adsorption capac-
ities of PCL NPs in aqueous solutions in batch experiments. Initial experiments were carried out using a constant 
LPS concentration (150 µg/ml) treated with different PCL concentrations (0.1, 25, 50, 100, 200, 300, 400, 500, 750 
and 1000 μg/ml) in: (i) RO water (pH ~6); (ii) phosphate buffered saline (PBS; 150 mM, pH ~7.4); (iii) bovine 
serum albumin (BSA) solutions in water and PBS; (iv) Trastuzumab (TTZ; Genentech) solutions in water and 
PBS; (v) Fibrinogen (Alfa Aesar) in PBS and (vi) Human Hemoglobin (MP Biomedicals) in PBS. The composition 
of PBS is as follows: 137 mM NaCl, 10 mM phosphate, and 2.7 mM KCl at 25 °C. The LPS binding capacity to PCL 
NPs was analyzed using Bodipy (BOD) fluorescence displacement assay technique58,59. BOD is a fluorescent mol-
ecule that quenches its fluorescence intensity (F.I.) when it binds to LPS. The F.I. of BOD was used to determine 
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the LPS concentration in solution using a known standard calibration curve (Figs S1, S2). The F.I. measurements 
were carried out using a microplate reader (BioTek). Excitation and emission wavelengths for BOD were 485/20 
and 528/20 nm, respectively. RO water was used as a negative control. The background fluorescence intensities 
were subtracted to avoid any interferences. The percentage (%) LPS removal by PCL NPs from water and PBS was 
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Where, qe, K , n, and Ce represent the adsorption based binding capacity (μg LPS per mg PCL NPs), Freundlich 
(binding affinity) constant (μg LPS per mg PCL NPs), Freundlich exponent and equilibrium LPS concentration 
(μg LPS/ml solution), respectively.
Protein recovery. Protein recovery in LPS spiked sample solutions was quantified using BCA assay kit 
(Pierce). The absorbance at 562 nm was measured in a microplate reader (BioTek). Different concentration of 
BSA, TTZ, fibrinogen and human hemoglobin were used for plotting the individual protein’s standard curves 
(Fig. S3). All assays were performed by the manufacturer’s instructions.
Effects of buffer and pHs on LPS removal. The effect of different buffers on LPS binding efficiency was 
analyzed by interacting a fixed PCL NP concentration (1000 µg/ml) with a constant LPS concentration (150 µg/
ml) prepared using different buffer solutions recipes (Table S1) each having fixed ionic strength of 100 mM 
(0.1 M). Six different buffer pH values from 2.8–9.6 were tested. Glacial acetic acid was used to obtain a pH 
value of 2.8. Phosphate buffers were prepared from monobasic and dibasic salts of 0.2 M sodium phosphate to 
obtain pH values of 5.8, 6.8 and 860–62. PBS of sodium bicarbonate were used to prepare pH 7.4 and 9.6 buffers, 
respectively60–62.
Effect of salt concentration on protein recovery. To investigate the effect of salt concentration on % 
protein recovery, 1000 μg/ml of each BSA and TTZ were spiked with 150 μg/ml of LPS in the different range of 
PBS concentrations: 0, 0.1, 1, 10, 100 and 150 mM. Protein concentrations were measured before and after LPS 
spiking and used to further calculate the % protein recovery.
PCL NP regeneration studies. PCL NP suspension was interacted with fixed LPS concentration (270 µg/
ml) in RO water and then centrifuged to obtain the supernatant which was reacted with BOD to calculate the per-
cent LPS removal efficiency using equation (1). The PCL NP pellet was resuspended in 0.2 N sodium hydroxide 
(NaOH) solution for 2 h and then centrifuged to remove the NaOH supernatant. The PCL NP pellet was washed 
five times using RO water before reusing it again for LPS binding. This regeneration cycle was repeated three 
times to measure any loss in LPS binding efficiency for PCL. The LPS removal efficiency of PCL NPs after each 
washing cycle was measured using the BOD fluorescence assay.
Synthesis of cellulose acetate (CA) membrane. The CA membranes with or without PCL NPs were 
prepared by a non-solvent induced phase separation process63. A casting solution was prepared by dissolving 10 
wt.% each of CA and 5 wt.% Pluronic F127 in dimethyl sulfoxide (DMSO) (control). For membranes with NPs, 1 
wt.% of PCL NPs was dispersed in the casting solution under vigorous stirring (1100 rpm) at 50 °C for 1 h to allow 
homogenous mixing and the solution was then left for 2 h to allow the complete release of bubbles. The final solu-
tion was cast on a casting plate and then immersed in RO water coagulation bath for 30 min. Finally, the water wet 
membrane was immersed in 30% glycerol (plasticizer) for 15 min, which in addition to improving the mechanical 
properties also help in dry storage of the membrane for at least 300 days with no major loss in membrane flux and 
removal properties64. The mass loading of PCL NPs in CA membranes was quantified by comparing the weights 
of 10 randomly freeze-dried membrane pieces of the same area (1.8 cm2) before and after adding the NPs. The 
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measured weight difference of the membranes with and without NPs is the mass of PCL NPs added to the mem-
brane and was used to calculate LPS removal per unit mass of PCL NPs.
Microscopy and microanalysis. The CA membranes with or without PCL particles were dried using the 
freeze-fracture method65. Samples were attached to an SEM stub and sputter coated with Denton Au/Pd coater. 
The membrane surface and cross sections were imaged using the Hitachi S-4700 SEM operated at 3 kV. The 
membrane surface and cross-sectional morphology, pore size, and thickness were analyzed using ImageJ soft-
ware (version 1.51w). The average membrane pore size and thickness were based on 100 randomly selected pores 
and points from different images. The results were reported as average ± standard deviation (SD). The presence 
of PCL NPs in the membrane was further verified using fluorescein isothiocyanate (FITC; 1 wt%) incorporated 
PCL NPs and fluorescence microscopy (Zeiss) equipped with 470 ± 40/525 ± 50 nm excitation/emission filters.
Permeation studies. The measurement of permeation flux was conducted using a custom-made membrane 
test apparatus (Fig. S4). The apparatus was made of two polyvinyl chloride flow pipes that hold the membrane 
in between like a sandwich. Each flow pipe is 1.5 cm wide. The top and bottom pipes are 20 cm and 10 cm long, 
respectively. The membrane area was 1.8 cm2. In each experiment, a volume of 20 ml water or solution was fed to 
the top pipe in a batch setup and flowed through the membrane by gravity. For LPS mixed water, a concentration 
of 270 μg/ml LPS in 20 ml water was used. Water was collected from the end of the bottom pipe. The water volume 
was measured at 1 h interval for 8 h to calculate the change in water flux.
Quantification of LPS removal using PCL NPs in CA membranes. The determination of LPS 
removal by CA membranes with or without PCL particles was also carried out by BOD fluorescence displacement 
assay technique58,59 and the apparatus introduced above. A volume of 20 ml RO water containing 270 μg/ml of 
LPS was fed to the top flow pipe to flow through a sandwiched membrane by gravity. A fixed volume (277 µL) of 
the LPS feed and the permeate was collected every hour until 8 h. The samples were mixed with BOD (262.11 µg/
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where FIBOD, .FIBOD LPS in permeate, and .FIBOD LPS in feed are the F.I.s of BOD alone, BOD mixed with LPS in permeate, 
and BOD mixed with LPS in the feed solution, respectively. Each value used here was based on triplicate measure-
ments from three independent experiments. The mean differences and standard deviations were also evaluated.
Calculation of LPS removal efficiency per unit mass and surface area of PCL NPs. The LPS 
removal efficiency per unit mass and surface area were calculated for PCL NPs used in powder form or in the CA 











where c is the concentration of particles in solution in g/ml, ρ is the density of PCL NPs in g/ml, and dp is the 
particle diameter in µm. The mass loading of PCL NPs entrapped in a CA membrane was measured from the 
mass difference of the freeze-dried CA membranes with and without NPs. The LPS removal efficiency per unit 
cm2 and per unit milligram of NPs was calculated based on the mass of LPS in the feed solution and the maximum 
% LPS removal.
Results
Removal of LPS from water and PBS using PCL NPs in powder form. The size of PCL NPs was 
observed to be ± nm780 285  in diameter by analyzing SEM images (Fig. 1a) and DLS technique (Fig. 1b), 
which, relatively speaking, is fairly uniform with a low level of dispersity in size. The surface morphology shows 
that the NPs were of highly spherical shape and their surfaces appeared to be closely packed without apparent 
pores leading into the interior of the particles. The ζ  potential of PCL NPs was found to be − ± mV20 5  in water 
(Fig. 1c) indicating a stable dispersion that resists aggregation. LPS adsorption tests were carried out with PCL 
NPs in both water (open circles; dotted line; Fig. 2a) and PBS (filled, solid circles; solid line; Fig. 2a) where initially 
the concentration of PCL NPs was systematically varied from 0 to 1000 μg/ml in both cases at a fixed LPS spiked 
concentration of 150 μg/ml and then the concentration of PCL NPs was fixed and the concentration of LPS was 
varied from 0.1 to 150 μg/ml in RO water. It was clear and important to note first that PCL NPs were effective in 
adsorbing and removing LPS from solutions regardless of the presence or absence of salts (PBS). In general, the 
removal efficiency of LPS by PCL NPs increased with increasing PCL NP concentration, which was to be expected 
due to increasing numbers of active sites available in the system for binding to LPS. The maximum level of LPS 
removal achieved was 98% when the PCL NP concentration of c = 1000 μg/ml was used under the positive influ-
ence of salts. Without salts, the LPS sequestration from water was only ~1.8% at a low NP concentration of 0.1  μg/
ml and increased to 9% and 82% when the NP concentration became 100 and 1000 μg/ml, respectively. The result 
at c = 1000 μg/ml was used to evaluate the LPS removal efficiency with varying LPS concentrations of 0–150 μg/
ml in water (Fig.  2b). The maximum LPS removal efficiency was ~95%, which was approximately 
~ endotoxin units EU cm2040 ( )/ 2 or ~1.3 × 106 EU/mg of PCL NPs (Table S2).
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Across the whole concentration range, the LPS adsorption increased with the addition of salt (PBS; pH 7.4) to 
water (solid circles; Fig. 2a). This positive effect was clearly exhibited by the data beyond any uncertainty of meas-
urement and indicated that increased ionic strength by the addition of salts resulted in higher LPS adsorption on 
the PCL NP surface. It is possible that at this high salt concentration (150 mM PBS) a strong interaction between 
water molecules and salts creates a shielding off effect leaving less water available for the induction of interactions 
between LPS and PCL. This behavior is consistent with the previously published literature66–71. Another possible 
explanation could be an electrostatic screening effect that reduces the repulsive interaction between two moieties 
carrying the same type of charges. Although both LPS and PCL can generally be considered hydrophobic mole-
cules, the former exhibits a net negative charge due to its phosphate groups33 and the latter also possesses partial 
negative charges in its carbonyl oxygen atoms. The repulsion between these negative charges can be understood 
to be weak relative to the van der Waals and hydrophobic binding46 between the two massive molecules and hence 
unable to impede the overall binding interaction and adsorption between LPS and PCL. However, this repulsion 
can be further weakened, thereby giving rise to stronger binding interaction and heightened adsorption, by the 
presence of salt ions in proximity to the negative charges that shield their like-charge interactions.
Removal of LPS from protein solutions using PCL NPs. To study the effectiveness of PCL NPs on 
removing LPS at the common contamination level from 0–150 μg/ml in biopharmaceutical solutions, two protein 
solutions were investigated. For this purpose, BSA and TTZ protein solutions (~1 mg/ml) in PBS of pH 7.4 and 
RO water containing either low or high levels of LPS were exposed to 1000 μg/ml PCL NPs (Fig. 3a). It is worth 
noting that the % LPS removal was higher (90–100%) in PBS (solid lines, Fig. 3a) than in water (dotted lines, 
Fig. 3a) indicating that PCL NPs were effective in removing LPS from pharmaceutical protein formulations72. We 
further tested the effects of protein concentration on LPS removal by analyzing four different protein solutions 
spiked with a fixed concentration (150 μg/ml) of LPS (Fig. 3b). Increasing protein concentrations from 250 to 
1000 μg/ml did not alter the ~90% LPS removal efficacy in PBS (solid lines, Fig. 3b) by PCL NPs (1000 μg/ml). In 
the case of BSA and TTZ in water, the % LPS removal dropped from 95% to ~ 80% with the increment in protein 
concentrations. This reduction of LPS binding on PCL NPs at high protein concentrations in water could be either 
due to: (i) exchange of low affinity of the highly abundant protein binding with the NP surface by the lower 
Figure 1. Characterization of PCL NPs. (a) An SEM image of PCL NPs at 50,000 X magnification. (b) Plot 
showing size distribution of PCL NPs. (c) Zeta potential of PCL NPs in water. Three colors indicate three 
independent runs.
Figure 2. The LPS removal efficiency of PCL NPs from water and PBS. (a) The percent (%) LPS removal from 
water (open circles, •; dotted line) and PBS (filled, solid circles, •; solid line) following adsorption on PCL NPs. 
*** indicates the p-value < 0.005 showing a statistically significant difference between % LPS removal in water 
and PBS. A fixed LPS concentration of 150 μg/ml was used in this study. (b) Water containing low (0.1 μg/ml) to 
high (150 μg/ml) LPS concentrations were treated with 1000 μg/ml of PCL NPs that gives ~95% LPS removal.
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abundance of LPS with a higher affinity for the NP surface; and/or (ii) formation of large aggregates between 
LPS-protein molecules desorbing LPS from the NP surface. In PBS, the % LPS removal from protein solutions 
was higher than that in water presumably due to more stable LPS-PCL NP complex formation surrounded by ions 
in bulk solution. On a preparative scale, an important indicator of desirable properties from such NP adsorbents 
is the adsorption capacity per unit mass. For this purpose, the equilibrium LPS adsorption capacity of PCL NPs 
was calculated up to . × EU mg1 4 10 /6  with ~100% LPS removal capacity from BSA, TTZ, fibrinogen and human 
hemoglobin solutions in PBS of pH 7.4 (Tables S3–S6).
LPS adsorption behavior on PCL NPs. Based on the experimental data of LPS binding on PCL NPs, 
binding-dependent parameters were calculated using the Freundlich isotherm model that rationalizes the contri-
bution of favorable adsorption on the NP surface. The experimental data fit the Freundlich model (R2 > 0.98) 
where the slope 
n
1  accounts for the intensity of adsorption and intercept, K  measures the binding affinity (μg LPS/
mg PCL NPs) (Fig. 4). >n 1 represents favorable adsorption associated with multilayer LPS formation on the 
Figure 3. The LPS removal efficiency of PCL NPs from protein solutions. (a) Increasing LPS or (b) protein 
concentrations have no significant effect on the % of LPS removal from protein solutions prepared in water and 
PBS. Symbols •, ο, ▪, ▲, ♦ indicate LPS containing BSA solutions in PBS, BSA in water, trastuzumab (TTZ) 
solutions in PBS, TTZ in water, Fibrinogen in PBS and Human hemoglobin in PBS respectively.
Figure 4. Freundlich adsorption isotherm fitting of LPS removal by PCL NPs from BSA and TTZ solutions in 
water and PBS.
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PCL surface73,74. From Table S7, it can be seen that the binding intensity (n) values vary from 1.1–1.4 thus indicat-
ing that the NPs have favorable LPS binding adsorption performance for all tested conditions75. The binding 
affinity constant, K was found to vary between 9.5–11.7 μg LPS/mg PCL NPs (∼ -10 10 EU/mg5 6 ) depending on 
the solution (water and PBS) and protein types (BSA and TTZ). The K values were compared with previously 
reported sorbents76–79 which indicated that PCL NPs were 10 to 40 log orders of magnitude better in LPS binding 
capacity than most of the commonly used adsorbents such as Polymyxin B conjugated cellulose microspheres and 
Histidine immobilized silica gels, among others76–79. To tease out the interactions between LPS and PCL NPs, the 
NPs were coated with a cationic polymer, PLL (Fig. S5). The PLL coated PCL NPs showed a significant decrease 
in % LPS removal from 80% to 60% in water and from 100% to 20% in PBS. These findings reassert the selective 
hydrophobic interactions between LPS and PCL NPs.
Protein Recovery
Most biopharmaceutical purification processes suffer from product loss. Protein recovery is as important as LPS 
removal to reflect an interaction of the protein with LPS binding sites. Figure 5 shows the results of protein recov-
ery at varying (a) LPS and (b) protein concentrations. As it is seen that protein recoveries were close to 100% for 
a wide range of LPS (0–160 μg/ml) and protein (0–1000 μg/ml) concentrations. These results further confirm the 
selectivity of PCL NPs for LPS while showing 100% protein recovery.
Effect of pH on LPS removal in different buffer conditions. The percentage of LPS removal was pre-
dicted to be dependent on the changes in buffer pH (Fig. 6a). LPS binding on PCL NPs show reasonably strong 
dependence on pH for different buffers of variable pHs. The ionic strength for all buffers was maintained constant 
Figure 5. Percentage of protein recovery as a function of (a) protein concentrations and (b) LPS concentrations. 
The amount of PCL NPs used was 1000 μg/ml.
Figure 6. The effects of pH and salt concentrations on LPS removal by PCL NPs. (a) The effect of pH and buffers 
on the % LPS removal. Four different types of buffers (acetic acid, phosphate, PBS and sodium bicarbonate) 
covering pH range from 2.8–9.6 were used. (b) Dependence of protein recovery on salt concentrations in LPS 
and PCL NP systems. Solid line with filled, solid circles (•) represents BSA and the dotted line with filled, solid 
squares (▪) indicates TTZ.
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at 100 mM (0.1 M). At the pH of 2.8, i.e., near and below the isoelectric point (pI 2) of LPS80, the binding of LPS 
with PCL NPs increased close to ~90% possibly due to low LPS solubility near the pI and high hydrophobic 
interactions between non-polar LPS and PCL resulting in increased LPS removal from the solution. On the other 
hand above the pI of LPS, at pHs between 5.8 and 8, average LPS removal efficiencies were found to be increased 
from 30% up to 90% in an alkaline buffer pH of 9.6. The enhancement in LPS removal at high pH is most likely 
due to hydrophobic interactions between non-polar LPS and PCL NPs that segregate the polar ions and water 
molecules and minimizes the area of contact between polar and non-polar molecules in the solution81. The phase 
separation of LPS was further enhanced up to ~99% by PBS of higher ionic strength (0.15 M, pH 7.4) driving 
the self-assembly of LPS-PCL NP hydrophobic effects. In summary, PCL NPs can operate in acidic to neutral 
conditions (pH 2.8 to pH 9.6). The highest LPS removal (~100%) was found in PBS of pH 7.4 followed by > 85% 
recovery in acetic acid and sodium bicarbonate buffer of pH 2.8 and 9.6, respectively.
Effect of salt concentration on protein recovery. Figure 6b shows that the % protein recovery is almost 
linear that varies between 90 to 100% with the change in salt concentrations indicating that the ionic strength 
has a little effect on protein recovery in our LPS-PCL NP system. At low salt concentrations extrapolated from 
zero salt concentration (water), the recovery was >90% for both BSA and TTZ which were increased further up 
to ~100% at higher salt concentrations (150 mM). These results indicate that the low affinity of proteins towards 
PCL NPs both in the absence and presence of solution ions. The mutual interactions between LPS and PCL NPs 
keep protein away in the bulk phase. At higher ionic strength, it is possible that free ions rearrange themselves into 
certain configurations around LPS-PCL NP complexes and proteins that promote increased retention of proteins 
in the mixture and thus slightly decrease the protein recovery to ~95%.
PCL NPs were regenerated to remove LPS. PCL NPs were regenerated by breaking LPS-PCL com-
plexes in RO water which makes the LPS removal process more efficient and scalable (Fig. 7). NaOH was used to 
regenerate the PCL NPs that exchanged off LPS for the hydroxide ( −OH 1) ion in the caustic solution which is 
well-known to desorb LPS from chromatography resins and particles quite effectively82–84. The collected PCL NPs 
were re-dissolved off the −OH 1, and this is facilitated by the 2 h contact time. A high LPS (EU/ml) recovery 
(~80%) was observed over the course of three regeneration cycles. An average LPS recovery of > ×2 106 EU/ml 
was obtained per regeneration cycle when LPS bound PCL particles were reacted with 0.2 N NaOH for 2 h and 
then washed using RO water before being reused for LPS binding again. Overall, the LPS removal efficiency of 
PCL NPs nearly had any change after three rounds if adsorption, elution, and reuse.
PCL NPs were embedded in CA membranes. The cross-sections of CA membranes were obtained by 
SEM (Fig. 8a) and compared with and without NPs. The original CA membrane exhibited a thickness of 116 ± 2 
μm and a relatively homogeneous macrostructure with a distinctive dense layer near the surface (Fig. 8a). Simply 
from the point of view of the ratio (~100) between the membrane thickness and the particle diameter, the pres-
ence of PCL NPs could be expected to have a great impact on the structural and transport properties of the mem-
brane. Indeed, the CA membrane with PCL NPs showed a seemingly more uniform cross-sectional structure with 
no unique layer (Fig. 8b), which was revealed fluorescence microscopy to contain green dye-labeled spherical 
PCL particles on the flat surface of the membrane (Fig. 8c). The cavities in the PCL embedded membrane were 
found to be noticeably larger than those in the original CA membrane as visualized from the SEM images of their 
cross-sections (Fig. 8a,b). While the incorporation of PCL NPs in the membrane appeared not to affect the pore 
opening size as there was only a slight change from 0.16 ± 0.05 μm to 0.17 ± 0.05 μm (Fig. S6), it has much greater 
impact on the membrane’s macro-void cross-sectional morphology as it changed from a narrow, tortuous, and 
flaky pore structure (Fig. 8a) to a broad, straight, and finger-like pore structure (Fig. 8b)63,85–90. PCL NPs also 
increased the membrane thickness by more than 13%, from 116 ± 2 μm to 132 ± 12 μm (Table S8).
Permeation of water using CA membranes without and with PCL NPs. The measurement of water 
flux driven by gravity-flow through CA membrane was illustrated in Fig. S4, which did not require any pumping 





 at the end of 1 h through the CA membranes without and with PCL NPs, respectively, and reduced to 




, respectively, at the end of 8 h of operation (Fig. 9a). These results were in agreement with previ-
Figure 7. PCL NP regeneration. LPS removal efficiency after PCL NPs is regenerated three times by desorbing 
LPS from the NPs using 0.2 N NaOH and testing for LPS adsorption/removal.
9Scientific RepoRts |          (2019) 9:8867  | https://doi.org/10.1038/s41598-019-45402-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
ously reported values91–93. Although the incorporation of PCL NPs appeared to create larger in size pores in the 
membrane structure (Figs 9a and 9b) that could be favorable for water to flow through, it also increased the mem-
brane thickness and hence the overall mass transfer resistance to water flow quite significantly, which may explain 
the resultant lower permeation fluxes. In addition, the presence of NPs occupying the pore space could also have 
a similar effect by resulting in significantly narrowed passageways for water flow. When LPS was mixed with 
water, the water fluxes were observed to be lowered as well (Fig. 9b). Specifically, the LPS-containing water fluxes 








 using the CA membrane embedded with PCL NPs. There could be a number of factors contributing to this 
phenomenon, which were considered not within the scope of this work but worthy of future studies. For example, 
the binding of LPS, being large elongated molecules, to the surfaces of the pores and PCL NPs could significantly 
reduce the pore sizes for water flow. The addition of LPS also changed the mass density of the solution which 
would certainly affect the gravity-driven flow through the membrane. These factors can be pursued in the future 
in order to obtain a deeper understanding and enable further optimization of the membrane pore structure for 
achieving even greater processability of the LPS-containing solutions.
CA membranes without and with PCL NPs for removing LPS from water. To confirm the adsorp-
tion capability of PCL NPs in a membrane form for potential application in larger scale operations, the LPS 
removal efficiencies by the CA membranes with or without PCL NPs were measured and compared. As can be 
seen in Fig. 10a, the incorporation of PCL NPs in membrane significantly boosted the LPS removal efficiency 
from ~48% to ~75% at the end of 1 h, and from 88% to near completion at the end of 8 h. The specific endotoxin 
units (EU) removed were further calculated and compared in Fig. 10b and Table S9, which clearly demonstrated 
the superior performance of PCL NPs in the membrane as compared to its pristine powder form. The removal 
efficiency per unit area was . ×~4 3 104 EU/cm2 (~ . ×2 8 106 EU/mg of PCL NPs), which was 2-fold (p < 0.005) 
higher than that of NPs alone (Table S9). These results indicate a promising avenue for removing LPS without the 
requirement of any pumping devices or external power sources through the utilization of PCL NPs both in pow-
der and membrane forms.
Figure 8. Characterization of PCL NP embedded filter. SEM images of the cross-sections of membranes 
prepared from (a) CA membrane, scale bar = 100 μm, (b) CA membrane with PCL NPs in low magnification, 
scale bar = 100 μm and (c) Fluorescence microscopic images of fluorescein dye encapsulated PCL NPs in 
membranes in high magnification.
Figure 9. The water flux performance of CA membrane (open circles; ○) and CA membrane impregnated with 
PCL NPs (filled, solid circles; •) (a) in the absence of LPS and (b) in the presence of LPS. The flow rates were 
measured under gravity. Error bars represent standard deviations from three independent experiments. * and 
** indicates p values of 0.03 and 0.01, respectively, representing statistically significant differences between the 
CA membrane and PCL NPs in CA membrane.
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Product Comparison
PCL NPs and PCL NP retaining membranes were compared against five commercially available endotoxin 
removal products (Fig. 11 and Table 1) following the manufacturers’ instructions. A neutral pH 7.4 PBS solution 
containing ~2.8 ×106 EU/ml of endotoxin was loaded in the presence of each product to determine the LPS 
clearance and protein recovery. PCL NPs and membranes showed 1.25 to 30-fold higher efficiency than other 
commercially available products.
Discussion
Relatively few polymers have been investigated for their potential to be synthesized into NP adsorbents for LPS 
removal. On a preparative scale, an important indicator of desirable properties from such NP adsorbents is the 
adsorption capacity per unit mass. In this work, the equilibrium adsorption capacity of PCL NPs in powder form 
and in the membrane was found to be more than . × EU mg2 8 10 /6  of NPs as shown in Tables S2–S6 and Table S9. 
Previously, polymyxin B cross-linked cellulose porous microspheres of ~150 μm in diameter have been shown to 
have a maximum adsorption capacity of 3.6 × 106 EU/mg77. These porous beads, despite offering a high internal 
surface area for LPS adsorption, also present hindered intraparticle mass transport within their porous structure 
so that their use in a membrane or in a chromatographic column requires a large pressure drop94. One way to 
Figure 10. The LPS removal efficiency of PCL NP embedded filters. (a) Efficacy tests of CA membrane (open 
circles; ○) and CA membrane with PCL NPs (filled, solid circles; •) for the removal of LPS from the water. 
= µC LPS270 g
ml0
 and PCL dose µ≈ g cm1670 / 2of membrane. *, ** and *** indicate p values of 0.03, 0.01 and 
less than 0.005 respectively, demonstrating statistically significant differences between PCL NPs in CA 
membrane and CA membrane. (b) Bar plot of LPS removed (EU)/mg of PCL NPs in powder form and also in 
CA membrane. The extent of error bar for PCL NPs in CA membrane is small due to the fact that the percentage 
LPS removal reached ~100%. The difference between PCL NPs in powder and in the membrane is statistically 
significant (p < 0.05).
Figure 11. Product comparison. PCL NPs show higher LPS binding capacity as well as higher protein recovery 
than five commercially available endotoxin removal products.
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circumvent this challenging issue of high pressure drop associated with high internal adsorption capacity is to use 
a nonporous solid adsorbent particle that has sufficient capacity on the exterior surface to achieve high adsorption 
efficiency at short residence time and under low pressure drop. As a type of such desirable adsorbent particles, 
PCL NPs of ~780 nm in diameter have a BET specific area of ≈ . m g6 5 /2  that provides 82–98% LPS removal effi-
ciency in water and PBS. These data are comparable to other previously reported processes46,77,79 and indicative of 
the potential of PCL NPs to fill the gap as a suitable adsorbent for LPS removal.
The extent of LPS removal was found in previous studies to depend on the characteristics of the buffer solu-
tion, including salt concentration and pH. Increasing the ionic strength was found to enhance the LPS adsorption 
on Q-sepharose gel column67. The LPS adsorption levels were 102 and 103 EU/ml in 10 and 50 mM PBS, respec-
tively67. Similar high LPS binding properties were shown by hydroxyapatite, polystyrene, Dowex 1-X2, activated 
charcoal, phenyl- and octyl-sepharose in presence of a high concentration of ammonium sulfate salts69. Our PCL 
NPs were found to remove more than 106 EU/ml using 150 mM PBS containing 137 mM NaCl (Figs 2–5), which 
represents an adsorption level almost 1000 fold higher than those of the previously published results. The effects 
of pH (protons) are also contingent on the electrostatic properties of the adsorbents68,95. In this work, the adsorp-
tion driving forces between the generally hydrophobic PCL NPs (adsorbent) and LPS (adsorbate) are dominated 
by the van der Waals interactions and hydrophobic binding, which are further enhanced by increasing pH that 
weakens the repulsion between the adsorbent and the adsorbate as both possess partially negatively charged 
moieties. The enhancement in LPS binding to hydrophobic PCL surface can be attributed to the weakening of 
the shielding effect common with water molecules which cannot wet the hydrophobic surface and instead form 
highly ordered shell-like structure or shield around the hydrophobic surface due to its inability to form hydrogen 
bonds in all directions, thus enhancing the interaction between two hydrophobic surfaces (LPS and PCL)66–71.
Combinedly, our results suggest that the highly effective LPS separation could be due to synergistic van der 
Waals and hydrophobic-hydrophobic interactions driving the selective LPS binding with the PCL NP surface. The 
hydrophobic interaction of LPS lipid tails with PCL NPs allows recruitment and assembly of LPS molecules on 
the NP surface. This process is synergized further due to the hydration of LPS polar head groups by the partially 
positively charged hydrogen ions of water. When LPS and PCL NPs are introduced to a protein solution, water 
molecules may rearrange by forming hydrogen bonds surrounding the LPS-PCL nanoparticle complex shell, thus 
effectively secluding the access of proteins to the particles. Because of this unstable nature of partial hydrogen ion 
plane surrounding the LPS-PCL NP complexes as well as individual observations, a wide variation in standard 
deviation was measured in water. In contrast, the presence of lyotropic salts like sodium chloride in PBS interacts 
strongly with these water molecules thus leaving less water available for the shielding effect to take place.
The effect of different buffers at variable pH’s and constant ionic strength was investigated (Fig. 6). Isoelectric 
point for LPS is at pH 2, hence LPS is negatively charged at pH > 280. PCL NPs, on the other hand, has an isoelec-
tric point at around pH 496 and thus are positively charged at pH < 4 and negatively charged for pHs > 4. At pH 
2.8 (acetic acid buffer), LPS would be negatively charged and PCL will have a positive charge, hence in addition 
to strong hydrophobic and van der Waals interaction, ionic interaction contributes towards LPS binding on PCL 
and thus a high LPS removal of ~90% was observed. The presence of acetate ion (CH3COO−) which is a lyotrope 
also helps in enhancing or promoting the hydrophobic interaction even further. As the buffer pH increases greater 
than 4, both PCL NPs and LPS exhibit negative charges due to their carbonyl and phosphate groups respectively. 
Based on these results, it can be concluded that in case of phosphate buffer (pH 5.8–8) the repulsion between LPS 
and PCL NPs dominates the hydrophobic and van der Waals interactions and therefore results in reasonably low 
LPS removal efficiency varying between 30–75%. For sodium bicarbonate buffer (pH 9.6), there was a sharp rise in 
LPS removal efficiency up to ~90%, indicating that the hydrophobic and van der Waals interaction dominates the 
repulsion action between PCL and LPS molecules at high pH. One major advantage of the biocompatible PCL par-
ticles is that they can be reused for LPS binding quite effectively without a major loss in binding efficiency (Fig. 7).
The LPS removal efficiency is further increased when PCL NPs were incorporated into a CA membrane, 




 (Fig. 9a,b)97. The 
porous CA membrane structure (Fig. 8a) has a small thickness (Table S6) and a favorable pore size distribution to 
not require high pressure drops for water flow across the membrane. Further insight in this respect can be 
obtained from an analogy using the Hagen-Poiseuille equation,
Product Name
Maximum Endotoxin 
Binding capacity (EU/ml) Cost ($) Reusability
Pall Acrodisc Unit with Mustang E membrane 5.0 × 105 $ 9.2 per 1 cm2 membrane area Yes
Millipore charged Durapore cartridge membrane filters >5.0 × 105 $ 2.7 per 1 cm2 membrane area Yes
BioRad Proteus Endotoxin Removal Kits (Membrane based) 5.0 × 105 − 106 $ 12.4 per 1 cm2 membrane area Yes
Sartobind Q100 membrane adsorbers (Sartorius) 1.0 × 106 NA Yes
Thermo scientific Pierce High capacity endotoxin removal resins 2 × 106 $ 20.2 per ml of resin slurry Yes
PCL nanoparticles 1.45 × 106 $2.4 per 1 g Yes
PCL nanoparticles incorporated membrane 2.8 × 106 $ 0.05 per 1 cm2 membrane area Not tested yet
Table 1. Comparison of PCL NPs and the NP containing membrane versus four commercially available 
endotoxin removal products.






where the pressure difference (∆P) can be related to µ = = . × ⋅−viscoty of water Pa s8 9 10 4 , =L membrane
= × − mthickness 130 10 6 ,  = = = . ×
.
−q volumetric flow rate m s25 6 9 10 /L
m h
6
2  and = =a pore diameter
. × − m0 17 10 6 . The resultant ∆P is equivalent to a low value of 63 Pa, which confirms the unnecessity of any 
pumping device for the solution to pass through the membrane to allow the adsorption removal of LPS to take 
place on the inside by the PCL NPs.
It is worth mentioning here that one direction for future study is to optimize the membrane pore structure to 
achieve higher productivity flowrates without sacrificing the loading and adsorption capability of PCL NPs. Some 
possibilities98 in this regard could result from using more branched cellulose polymers, additives or cross-linkers, 
and templated casting surface. In addition, a very preliminary cost analysis was performed (Table 1) to get an idea 
of the costs associated with manufacturing the PCL NP embedded CA membrane. The result was acceptably less 
than a dollar per cm2. However, more extensive and rigorous analysis is needed when an actual process is being 
designed or in operation, which needs to take into account labor, utilities, storage, and other process variables 
including potentially pumping devices.
Conclusion
In this study, we report first the synthesis of polymeric PCL NPs by employing a solvent evaporation method 
and then the performances of PCL NPs for the adsorption and removal of LPS. It was found that PCL NPs in 
powder form removed around 88% of LPS from the water sample. The presence of salts via the addition of PBS 
increased the LPS removal efficiency further up to 100% by PCL NPs, while maintaining 100% protein recovery 
from solutions. This high removal efficiency of LPS from water and PBS attributed to strong hydrophobic and van 
der Waals interaction. Buffers of variable pH play a very important role in determining the LPS binding on PCL. 
Acidic (pH 2.8) and alkaline (pH 9.6) buffers give ~90% LPS removal whereas intermediate pHs from 5.8 to 8 give 
reasonably lower % LPS removal between 30–75%. The adsorption efficiency reached almost 100% when PCL 
NPs were incorporated into the CA membrane where the water flow through the porous structure was directly by 
gravity without the requirement of any pumping devices. The biocompatible PCL NPs can be reused by desorbing 
majority of adsorbed LPS using 0.2 N NaOH solution. A preliminary cost analysis showed that the manufacturing 
cost of the PCL NP embedded CA membrane is quite affordable. These findings coupled with PCL NP’s known 
biodegradability support the potential of hybrid NP-membrane system to be used in large-scale operations that 
remove LPS efficiently and reduce the downstream process costs in biotechnological industries.
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